Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f53faaffb7927528e143e345d5d58130 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-567 |
filingDate |
2008-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df91656a36b5a597f0da8147a0af18ab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c87ebae95a7361bc9af5e582c2d6988 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d35cc6b8b9177b49d91719b477e714d |
publicationDate |
2010-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2211845-A2 |
titleOfInvention |
Glucocorticoid receptor antagonists such as mifepristone for treating cushing's syndrome |
abstract |
The invention relates to a method for treating Cushing s syndrome in a patient, which method comprises administering the patient with a pharmaceutical composition comprising a glucocorticoid receptor antagonist, at least twice a day, or an extended- release composition of a glucocorticoid receptor antagonist, or a combination of a glucocorticoid receptor antagonist and a inhibitor of cortisol synthesis. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013190097-A1 |
priorityDate |
2007-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |